Top compounds associated with response to RP11-136C24.3


Feature Type Standardized
Nominal ANOVA
mRNA quizartinib CTRPv2 pan-cancer AAC -0.011 0.8
mRNA selumetinib:decitabine (4:1 mol/mol) CTRPv2 pan-cancer AAC -0.0097 0.8
mRNA JW-74 CTRPv2 pan-cancer AAC 0.013 0.8
mRNA SR1001 CTRPv2 pan-cancer AAC -0.011 0.8
mRNA BMS-345541 CTRPv2 pan-cancer AAC -0.01 0.8
mRNA BRD1812 CTRPv2 pan-cancer AAC 0.0097 0.8
mRNA tanespimycin:bortezomib (250:1 mol/mol) CTRPv2 pan-cancer AAC 0.01 0.8
mRNA hyperforin CTRPv2 pan-cancer AAC -0.011 0.8
mRNA ML083 CTRPv2 pan-cancer AAC -0.01 0.8
mRNA manumycin A CTRPv2 pan-cancer AAC -0.0084 0.8
Download CSV